Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2521 AL 2535

Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease

Forlenza OV, Diniz BS, Teixeira AL, Stella F, Gattaz W.

Braz J Psychiatry. 2013 Jul-Sep;35(3):284-94. doi: 10.1590/1516-4446-2012-3505.

Alzheimer's disease biomarkers: walk with deliberate haste, don't run blithely on?

Hu WT, Shaw LM, Trojanowski JQ.

Acta Neuropathol. 2013 Nov;126(5):625-9. doi: 10.1007/s00401-013-1197-3.

Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study

Mouton-Liger F, Wallon D, Troussière AC, Yatimi R, Dumurgier J, Magnin E, de la Sayette V, Duron E, Philippi N, Beaufils E, Gabelle A, Croisile B, Robert P, Pasquier F, Hannequin D, Hugon J, Paquet C.

J Neurol. 2014 Jan;261(1):144-51. doi: 10.1007/s00415-013-7160-3. Epub 2013 Oct 27.

Cerebrospinal fluid τ protein in differential diagnosis of Alzheimer's disease and vascular dementia in Chinese population: a meta-analysis

Liu B, Tang Y, Shen Y, Cen L, Han M.

Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):116-22. doi: 10.1177/1533317513507374. Epub 2013 Oct 27.

Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans

Deguil J, Ravasi L, Auffret A, Babiloni C, Bartres Faz D, Bragulat V, Cassé-Perrot C, Colavito V, Herrero Ezquerro MT, Lamberty Y, Lanteaume L, Pemberton D, Pifferi F, Richardson JC, Schenker E, Blin O, Tarragon E, Bordet R.

Drug Discov Today Technol. 2013 Sep;10(3):e329-42. doi: 10.1016/j.ddtec.2013.03.003.

[Biomarkers of the Alzheimer's disease: concepts and clinical case]

Bier JC.

Rev Med Brux. 2013 Sep;34(4):306-10.

[Early diagnosis of Alzheimer's disease]

Seppälä T, Herukka SK, Remes AM.

Duodecim. 2013;129(19):2003-10.

Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults

Nation DA, Edland SD, Bondi MW, Salmon DP, Delano-Wood L, Peskind ER, Quinn JF, Galasko DR.

Neurology. 2013 Dec 3;81(23):2024-7. doi: 10.1212/01.wnl.0000436935.47657.78. Epub 2013 Nov 13.

Alzheimer's disease: analyzing the missing heritability

Ridge PG, Mukherjee S, Crane PK, Kauwe JS; Alzheimer’s Disease Genetics Consortium.

PLoS One. 2013 Nov 7;8(11):e79771. doi: 10.1371/journal.pone.0079771. eCollection 2013.

The oxidative stress hypothesis in Alzheimer's disease

Padurariu M, Ciobica A, Lefter R, Serban IL, Stefanescu C, Chirita R.

Psychiatr Danub. 2013 Dec;25(4):401-9.

Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging

Motsinger-Reif AA, Zhu H, Kling MA, Matson W, Sharma S, Fiehn O, Reif DM, Appleby DH, Doraiswamy PM, Trojanowski JQ, Kaddurah-Daouk R, Arnold SE.

Acta Neuropathol Commun. 2013 Jun 27;1:28. doi: 10.1186/2051-5960-1-28.

Neuroimaging and the search for a cure for Alzheimer disease

Petrella JR.

Radiology. 2013 Dec;269(3):671-91. doi: 10.1148/radiol.13122503.

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020

Hampel H, Lista S, Teipel SJ, Garaci F, Nisticò R, Blennow K, Zetterberg H, Bertram L, Duyckaerts C, Bakardjian H, Drzezga A, Colliot O, Epelbaum S, Broich K, Lehéricy S, Brice A, Khachaturian ZS, Aisen PS, Dubois B.

Biochem Pharmacol. 2014 Apr 15;88(4):426-49. doi: 10.1016/j.bcp.2013.11.009. Epub 2013 Nov 22.

Cerebrospinal fluid apolipoprotein E concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease

Schmidt C, Becker H, Zerr I.

Am J Alzheimers Dis Other Demen. 2014 Feb;29(1):54-60. doi: 10.1177/1533317513505133. Epub 2013 Nov 24.

[Oxidative stress hypothesis for Alzheimer's disease and its potential therapeutic implications]

Nunomura A.

Rinsho Shinkeigaku. 2013;53(11):1043-5. doi: 10.5692/clinicalneurol.53.1043.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias